Dose-responsive insulin regulation of glucose transport in human skeletal muscle.

Glucose transport is regarded as the principal rate control step governing insulin-stimulated glucose utilization by skeletal muscle. To assess this step in human skeletal muscle, quantitative PET imaging of skeletal muscle was performed using 3-O-methyl-[11C]glucose (3-[11C]OMG) in healthy volunteers during a two-step insulin infusion [n = 8; 30 and 120 mU.min(-1).m(-2), low (LO) and high (HI)] and during basal conditions (n = 8). Positron emission tomography images were coregistered with MRI to assess 3-[11C]OMG activity in regions of interest placed on oxidative (soleus) compared with glycolytic (tibialis anterior) muscle. Insulin dose-responsive increases of 3-[11C]OMG activity in muscle were observed (P < 0.01). Tissue activity was greater in soleus than in tibialis anterior (P < 0.05). Spectral analysis identified that two mathematical components interacted to shape tissue activity curves. These two components were interpreted physiologically as likely representing the kinetics of 3-[11C]OMG delivery from plasma to tissue and the kinetics of bidirectional glucose transport. During low compared with basal, there was a sixfold increase in k3, the rate constant attributed to inward glucose transport, and another threefold increase during HI (0.012 +/- 0.003, 0.070 +/- 0.014, 0.272 +/- 0.059 min(-1), P < 0.001). Values for k3 were similar in soleus and tibialis anterior, suggesting similar kinetics for transport, but compartmental modeling indicated a higher value in soleus for k1, denoting higher rates of 3-[11C]OMG delivery to soleus than to tibialis anterior. In summary, in healthy volunteers there is robust dose-responsive insulin stimulation of glucose transport in skeletal muscle.

[1]  S. Kaul,et al.  Physiologic hyperinsulinemia enhances human skeletal muscle perfusion by capillary recruitment. , 2001, Diabetes.

[2]  C Bogardus,et al.  No accumulation of glucose in human skeletal muscle during euglycemic hyperinsulinemia. , 1988, The American journal of physiology.

[3]  D. James,et al.  Heterogeneity of insulin action in individual muscles in vivo: euglycemic clamp studies in rats. , 1985, The American journal of physiology.

[4]  J. Mazziotta,et al.  Positron emission tomography and autoradiography: Principles and applications for the brain and heart , 1985 .

[5]  J. Holloszy,et al.  Activation of glucose transport in muscle by prolonged exposure to insulin. Effects of glucose and insulin concentrations. , 1986, The Journal of biological chemistry.

[6]  C Cobelli,et al.  Kinetic modeling of [(18)F]FDG in skeletal muscle by PET: a four-compartment five-rate-constant model. , 2001, American journal of physiology. Endocrinology and metabolism.

[7]  G. Shulman,et al.  A novel 13C NMR method to assess intracellular glucose concentration in muscle, in vivo. , 1998, American journal of physiology. Endocrinology and metabolism.

[8]  A. Carruthers,et al.  Facilitated diffusion of glucose. , 1990, Physiological reviews.

[9]  Z Trajanoski,et al.  Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes. , 1999, The New England journal of medicine.

[10]  Alessandra Bertoldo,et al.  Quantitative assessment of glucose transport in human skeletal muscle: dynamic positron emission tomography imaging of [O-methyl-11C]3-O-methyl-D-glucose. , 2005, The Journal of clinical endocrinology and metabolism.

[11]  D. Newport,et al.  Evaluation of simulation-based scatter correction for 3-D PET cardiac imaging , 1995 .

[12]  S Minoshima,et al.  An automated method for rotational correction and centering of three-dimensional functional brain images. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[13]  J. Price,et al.  Interactions of impaired glucose transport and phosphorylation in skeletal muscle insulin resistance: a dose-response assessment using positron emission tomography. , 2001, Diabetes.

[14]  M.E. Casey,et al.  Evaluation of simulation-based scatter correction for 3D PET cardiac imaging , 1995, 1995 IEEE Nuclear Science Symposium and Medical Imaging Conference Record.

[15]  B. Kahn,et al.  Glucose transporters and insulin action--implications for insulin resistance and diabetes mellitus. , 1999, The New England journal of medicine.

[16]  H. Herzog,et al.  Quantification of glucose transport and phosphorylation in human skeletal muscle using FDG PET. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[17]  M. Clark,et al.  Role of blood flow in the regulation of muscle glucose uptake. , 1997, Annual review of nutrition.

[18]  D. Wasserman,et al.  Limitations to exercise- and maximal insulin-stimulated muscle glucose uptake. , 1998, Journal of applied physiology.

[19]  J. Mazziotta,et al.  MRI‐PET Registration with Automated Algorithm , 1993, Journal of computer assisted tomography.

[20]  J. Price,et al.  Insulin regulation of glucose transport and phosphorylation in skeletal muscle assessed by PET. , 1999, American journal of physiology. Endocrinology and metabolism.

[21]  A. Klip,et al.  Insulin-mediated translocation of glucose transporters from intracellular membranes to plasma membranes: sole mechanism of stimulation of glucose transport in L6 muscle cells. , 1988, Biochemical and biophysical research communications.

[22]  C Cobelli,et al.  Glucose Transport in Human Skeletal Muscle: The In Vivo Response to Insulin , 1993, Diabetes.

[23]  O. Pedersen,et al.  Glut 4 content in the plasma membrane of rat skeletal muscle: comparative studies of the subcellular fractionation method and the exofacial photolabelling technique using ATB‐BMPA , 1993, FEBS letters.

[24]  D. Wasserman,et al.  Analysis of insulin-stimulated skeletal muscle glucose uptake in conscious rat using isotopic glucose analogs. , 1998, American journal of physiology. Endocrinology and metabolism.

[25]  C Cobelli,et al.  A compartmental model to quantitate in vivo glucose transport in the human forearm. , 1989, The American journal of physiology.

[26]  Simon C Watkins,et al.  The effect of non-insulin-dependent diabetes mellitus and obesity on glucose transport and phosphorylation in skeletal muscle. , 1996, The Journal of clinical investigation.

[27]  C. Cobelli,et al.  Glucose transport and phosphorylation in skeletal muscle in obesity: insight from a muscle-specific positron emission tomography model. , 2003, The Journal of clinical endocrinology and metabolism.

[28]  N. Simionescu,et al.  The Cardiovascular System , 1983 .

[29]  D. Wasserman,et al.  Functional limitations to glucose uptake in muscles comprised of different fiber types. , 2001, American journal of physiology. Endocrinology and metabolism.